{"id":"tp-39741","type":"article-newspaper","title":"Doctors Call Moderna-Merck Melanoma Vaccine Trial Results Meaningful","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/39741","datePublished":"2026-10-24T07:06:10.000Z","dateModified":"2026-10-24T07:06:10.000Z","language":"en","abstract":"The combination lowered the hazard of recurrence or death by 42% in a 1,137-patient trial, but an overall-survival benefit has not been established.","section":"Business","references":[{"title":"earlier market coverage","url":"https://www.tokenpost.com/news/investing/38680"}]}